Social responsibility: openness of interaction

The effectiveness and safety of drug therapy depend not only on the quality of our products, but also on the quality of the information we provide to the medical community and the General public.

The information provided to medical professionals and distributors about our products and services should be useful, accurate and supported by scientific data.

The information about product availability and delivery should be up-to-date, provided in a proper way and as soon as possible.

We do not engage in dialogue about the product in order to promote it on the market before the product is intended for such use. This, however, does not limit our full and proper exchange of scientific information.